North America Mass Spectrometry Market Size and Forecast 2025–2033

According to Renub Research Latest Report North America Mass Spectrometry Market is projected to grow from US$ 2.6 billion in 2024 to US$ 4.87 billion by 2033, registering a robust CAGR of 7.21% from 2025 to 2033, driven by pharmaceutical, environmental, and food safety applications.

The North America Mass Spectrometry (MS) Market is expected to experience significant growth over the forecast period, expanding from US$ 2.6 billion in 2024 to US$ 4.87 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.21%. This expansion is fueled by the growing adoption of mass spectrometry across pharmaceutical, environmental, and food testing sectors, alongside technological advancements that enhance precision, sensitivity, and operational efficiency.

Mass spectrometry is an essential analytical technique that measures the mass-to-charge ratio of ions, providing detailed information on the composition, structure, and molecular weight of chemical compounds. By ionizing chemical substances to produce charged particles and separating ions based on their mass-to-charge ratio, MS enables highly accurate and reproducible analysis.

In North America, MS is widely applied across pharmaceutical research, biotechnology, environmental monitoring, forensic science, and food safety. The technique aids in drug discovery and development, supports regulatory compliance in environmental and food testing, and facilitates toxicology analyses in forensic investigations. As the demand for precise and reliable analytical tools grows, mass spectrometry continues to play a critical role in advancing science, technology, and public safety.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Sample Report

Key Growth Drivers in the North America Mass Spectrometry Market

1. Rising Demand in Pharmaceutical and Biotechnology Sectors

The pharmaceutical and biotechnology industries are the primary drivers of mass spectrometry adoption in North America. Increasing emphasis on precision medicine, biologics, and complex drug formulations has highlighted the need for analytical techniques capable of precise identification, quantification, and characterization of molecules.

Mass spectrometry is extensively used for drug development, pharmacokinetics, quality control, and biomarker discovery. A strong pipeline of clinical trials and stringent regulatory requirements further stimulate the demand for high-sensitivity MS instruments.

Notable Development: In December 2024, Roche received CE mark approval for its cobas® Mass Spec solution, comprising the cobas® i 601 analyser and Ionify® reagent pack, initially covering four steroid hormone assays. This launch marks the start of a global rollout to bring automated, standardized clinical mass spectrometry testing to routine laboratories, ultimately expanding the analysis to over 60 analytes including steroid hormones, vitamin D metabolites, immunosuppressants, and drugs of abuse.

2. Technological Advancements in Hybrid and High-Resolution Systems

The evolution of hybrid and high-resolution mass spectrometry platforms, such as triple quadrupole, Q-TOF, and Orbitrap systems, has been a key growth driver. These platforms offer enhanced precision, higher throughput, and the ability to analyze complex biological and environmental samples efficiently.

Hybrid systems enable simultaneous qualitative and quantitative analysis, saving time and improving laboratory efficiency. North America, home to major instrument manufacturers, benefits from rapid deployment of advanced technologies.

Example: In June 2025, Sciex revised its mass spectrometry portfolio, emphasizing the ZenoTOF 8600 system, which provides fast, high-resolution analysis of multiple molecular species in complex samples for applications in proteomics, metabolomics, and genomics.

3. Expanding Applications in Food Safety and Environmental Testing

Mass spectrometry is increasingly critical in food safety assurance and environmental pollutant monitoring. As regulations from the FDA, USDA, and EPA become more stringent, industries require highly sensitive instruments to detect pesticides, allergens, toxins, and chemical residues.

MS allows detection of contaminants at trace levels, ensuring regulatory compliance and consumer safety. Environmental applications include air, water, and soil analysis, aiding in public health protection and sustainability initiatives. Growing consumer demand for safe, high-quality food and environmentally responsible practices further drives market adoption.

Challenges in the North America Mass Spectrometry Market

High Equipment and Maintenance Costs

One of the major hurdles in the North American market is the high cost of MS instruments. Advanced systems like Orbitrap and Q-TOF may cost hundreds of thousands of dollars, making them a significant investment for smaller laboratories or academic centers.

Additional costs include annual service agreements, software upgrades, and operator training, limiting adoption. While leasing options and collaborative models exist, affordability continues to constrain widespread market penetration.

Complexity of Operation and Skilled Workforce Shortage

MS instruments require highly trained professionals for accurate operation and data interpretation. The complexity of calibration, maintenance, and analysis presents a barrier to broader adoption. In North America, the shortage of skilled workforce in proteomics and metabolomics can result in underutilization of instruments or analytical errors.

To overcome these challenges, stakeholders are investing in training programs, collaborations with academic institutions, and automated solutions that simplify workflow and reduce dependency on highly specialized personnel.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation Insights

Product Segmentation

Instruments: Single quadrupole, triple quadrupole, TOF, Orbitrap systems

Consumables & Services

Technology Segmentation

Hybrid Mass Spectrometry

Single Mass Spectrometry

Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

End-Use Segmentation

Pharmaceutical & Biotechnology Companies

Government & Academic Institutions

Others

Application Segmentation

Drug Discovery

Life Science Research

Clinical Diagnostics

Food Testing

Environmental Testing

North America Market Insights

Instruments Segment

Instrument sales form the largest revenue share in the North American MS market. Pharmaceutical companies favor triple quadrupole systems for quantitative analysis, while research institutions prefer Orbitrap or TOF systems for high-end proteomics applications. Continuous technological upgrades and replacement cycles sustain strong demand.

Hybrid Mass Spectrometry

Hybrid platforms combining quadrupole, ion trap, and TOF technologies are gaining traction due to their versatility and advanced features. They are extensively used in drug discovery, proteomics, metabolomics, and environmental analysis. Despite higher costs, hybrid systems are viewed as long-term assets due to their efficiency and broad applicability.

Single Mass Spectrometry

Single MS systems, such as single quadrupole instruments, remain popular for routine testing and entry-level applications, particularly in smaller laboratories and academic institutions. Their cost-effectiveness and ease of use maintain stable demand.

Applications and End-User Insights

Pharmaceutical & Biotechnology Applications

Pharmaceutical and biotech industries dominate MS usage in North America. MS supports drug discovery, clinical evaluation, pharmacokinetics, and biomarker identification, enabling personalized medicine and compliance with FDA and Health Canada regulations. The continued pipeline of novel therapies, biologics, and biosimilars ensures sustained market growth.

Drug Discovery

Mass spectrometry is critical in early-stage R&D, including target identification, lead optimization, and metabolic profiling. Hybrid systems like Q-TOF and Orbitrap enhance efficiency and reduce time-to-market for new treatments.

Food Testing

Food testing is a fast-growing MS application, driven by regulatory compliance and consumer demand for transparency. MS ensures accurate detection of pesticides, allergens, toxins, and food origin verification, supporting both safety and authenticity.

Regional Highlights

United States

The United States leads the North American MS market due to a strong pharmaceutical base, robust research infrastructure, and regulatory rigor. The U.S. is also home to major equipment manufacturers, ensuring early access to advanced technologies.

Example: In May 2025, Bruker Corporation introduced the timsOmni™ system, a timsTOF-based mass spectrometer for research, drug discovery, and clinical applications, offering insights into proteoforms and oligonucleotides.

Canada

Canada’s MS market is steadily expanding, with academic institutions, government labs, and healthcare research organizations driving adoption. MS supports drug discovery, proteomics, and environmental monitoring, with initiatives such as TMIC 2.0 launched in April 2023, covering nine research nodes nationwide to enhance genomics and metabolomics capabilities.

Competitive Landscape

Key players in the North American MS market include:

Agilent Technologies

Bruker Corporation

Danaher Corporation

Hitachi Ltd

JEOL Ltd

LECO Corporation

PerkinElmer Inc.

Thermo Fisher Scientific

These companies invest heavily in R&D, high-resolution and hybrid platforms, strategic partnerships, and market expansion, maintaining leadership in an evolving landscape.

Conclusion

The North America Mass Spectrometry Market is on a strong growth trajectory, driven by pharmaceutical R&D, technological innovation, and regulatory demands in food and environmental safety. Hybrid and high-resolution systems are gaining prominence, while single MS instruments continue to meet routine analytical needs. Despite challenges such as high costs and workforce shortages, the market remains robust, offering significant opportunities for manufacturers, research institutions, and end-users over the next decade.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.